Targeted Transposition For Use In Epigenetic Studies - EP2999784

The patent EP2999784 was granted to Active Motif on Nov 23, 2022. The application was originally filed on May 22, 2014 under application number EP14801374A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2999784

ACTIVE MOTIF
Application Number
EP14801374A
Filing Date
May 22, 2014
Status
Patent Maintained As Amended
Oct 21, 2022
Grant Date
Nov 23, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DIAGENODEOct 1, 2020HUENGESADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS2011189677
INTERNATIONAL-SEARCH-REPORTUS2011287435
INTERNATIONAL-SEARCH-REPORTWO2010048605
OPPOSITIONUS2006252140
OPPOSITIONWO2012061832
OPPOSITIONWO2012080591
OPPOSITIONWO2012106546
SEARCHUS2011287435
SEARCHWO2013078470

Non-Patent Literature (NPL) Citations (4) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- A. BECKER et al., "Direct Homo and hetero interactions of the MeCP2 and MBD2", PLOS ONE, (20130000), vol. 8, XP055768162-
OPPOSITION- C. KETTLUN et al., "Manipulating piggybac Transposon chromosomal integration site selection in human cells", Molecular Therapy, (20110000), vol. 19, no. 9, pages 1636 - 1644, XP055768160-
OPPOSITION- S. R. YANT et al., "Fusion proteins consisting of the sleeping Beauty Transposase and the Polydactyl Zinc Finger Protein E2C direct Transposon integration into a Unique Human chromosomal sequence", Molecular Therapy, (20050500), vol. 11, no. supplement 1, XP005016440-
SEARCH- MARIE-VERONIQUE DEMATTEI ET AL, "Site-directed integration of transgenes: transposons revisited using DNA-binding-domain technologies", GENETICA ; AN INTERNATIONAL JOURNAL OF GENETICS AND EVOLUTION, KLUWER ACADEMIC PUBLISHERS, DO, (20090807), vol. 138, no. 5, ISSN 1573-6857, pages 531 - 540, XP019789321 [X] 8,10 * figure 1 * * abstract * * the whole document *-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents